Daily Stocks Highlight by Insiderslab: Pfizer, Dendreon, Frontier, BP, Allergan, and Herbalife



Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Pfizer (NYSE:PFE), Dendreon (NASDAQ:DNDN), Frontier (NASDAQ:FTR), BP (NYSE:BP), Allergan (NYSE:AGN), and Herbalife (NYSE:HLF).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Pfizer Inc. (NYSE:PFE): In the last trading session, shares of Pfizer Inc. (NYSE:PFE) gained 1.39% to US$24.04 and made a new 52-week high of US$24.49. The rise of Pfizer shares is after the company’s releasing of second quarter 2012 financial results. For the latest quarter, revenues were US$15.1 billion, compared with US$16.5 billion in the same quarter of 2011, a decrease of 9%. Net income for the quarter was increased by 25% to US$3.3 billion, from net income of US$2.6 billion, a year ago. Pfizer Inc. has a market capitalization of US$180.01 billion with price range within US$16.63 - US$24.49 over the past 52 weeks. Since Pfizer insiders have better access to company non-public information, Insiderslab.com thinks that investors would be wise to pay close attention to their stock trading behaviors. Check this insider trade report for PFE here.
 
Read Full Report: http://www.insiderslab.com/PR3/080112B/PFE/Pfizer.pdf
 
Dendreon Corporation (NASDAQ:DNDN): For the second quarter of 2012, Dendreon Corporation (NASDAQ:DNDN) post a net loss of US$96.1 million, or US$0.65 per share, compared to a net loss of US$116.0 million, or US$0.79 per share, in the same quarter of 2011. Net product revenue for the quarter was increased by 66% to US$80 million, from US$48.1 million, year-over-year. What’s more, along with the second quarter financial report, Dendreon announced a restructuring plan with a view to accelerate the company’s path to profitability and future growth. Moreover, Dendreon plans to cut 600 employees in the next 12 months. By market close, shares of Dendreon tumbled 22.98% to US$4.76 with significant volume traded, which was 5 times more than usual. The stock made a new 52-week low of US$4.70 in the last trading session. Do you think Dendreon will rebound or continue to drop? Do you think now is a good time to sell the stock? Investors could get an idea by checking this insider trade report for DNDN here.
 
Read Full Report: http://www.insiderslab.com/PR3/080112B/DNDN/Dendreon.pdf
 
Frontier Communications Corporation (NASDAQ:FTR): For the second quarter of 2012, Frontier Communications Corporation (NASDAQ:FTR) announced profit was US$18.0 million, or US$0.02 per share, dropped from profit of US$32.3 million, or US$0.03 per share, prior-year’s level. Revenue for the latest quarter was US$1,258.8 million, compared with revenue of US$1,322.3 million in the second quarter of 2011. In the last trading session, Frontier shares advanced 5.66% to US$3.92 with hefty volume traded, which was 3.8 times more than average volume. Its price, as of the latest close, was up 28% compared with the 52-week low and was 94% below the 52-week high. Interested in the non-public stock trading behaviors of Frontier insiders? Investors can get the information they need by clicking the following link.
 
Read Full Report: http://www.insiderslab.com/PR3/080112B/FTR/Frontier.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
BP plc (ADR) (NYSE:BP):
Read Full Report: http://www.insiderslab.com/PR3/080112B/BP/BP.pdf
 
Allergan, Inc. (NYSE:AGN):
Read Full Report: http://www.insiderslab.com/PR3/080112B/AGN/Allergan.pdf
 
Herbalife Ltd. (NYSE:HLF):
Read Full Report: http://www.insiderslab.com/PR3/080112B/HLF/Herbalife.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
 
CONTACT: Insiders.hk, Insiderslab.com, info@insiderslab.com, Support@insiders.hk
SOURCE Insiderslab.com; Insiders.hk
Editor: Janet Nan Jiang
 
 
Source:
insiderslab.com
www.insiderslab.com

Reported on Aug 1, 2012

 
More Insider News ...

Today's Notable Trades


HYPERION THERAPEUTICS INC (HPTX)
Senior Officer (SVP & Chief Medical Officer): Scharschmidt Bruce Frederick

Acquired 13,402 Common Stock (Non-Derivative security at $7.310) on May 22, 2013. Direct holding 70,909 shares/units after transaction. Holdings increased 23.30%.
Filing date: May 24, 2013. Record updated at 22:25:49.
 
SALESFORCE COM INC (CRM)
Senior Officer (EVP, Customers for Life & CGO): Martinez Maria

Sold 2,490 Common Stock (Non-Derivative security at $43.110) on May 23, 2013. Direct holding 2,254 shares/units after transaction. Holdings decreased -52.49%.
Filing date: May 24, 2013. Record updated at 22:25:36.
 
Google Inc. (GOOG)
First-Class Insider (Executive Chairman of Board): SCHMIDT ERIC E

Sold 6,901 Class A Common Stock (Non-Derivative security at $871.630) on May 24, 2013. Indirect holding 53,579 shares/units after transaction. Holdings decreased -11.41%.
Filing date: May 24, 2013. Record updated at 22:23:34.
 
IXYS CORP /DE/ (IXYS)
Director: FEUCHT DONALD L

Acquired 6,600 Common Stock (Non-Derivative security at $8.610) on May 22, 2013. Direct holding 9,153 shares/units after transaction. Holdings increased 258.52%.
Filing date: May 24, 2013. Record updated at 22:23:16.
 
ServiceNow, Inc. (NOW)
First-Class Insider (PRESIDENT & CEO): Slootman Frank

Sold 5,100 Common Stock (Non-Derivative security at $38.557) on May 22, 2013. Indirect holding 32,400 shares/units after transaction. Holdings decreased -13.60%.
Filing date: May 24, 2013. Record updated at 22:20:30.
 
MASIMO CORP (MASI)
Director: Coleman Robert

Acquired 59,400 Common Stock (Non-Derivative security at $2.750) on May 22, 2013. Direct holding 129,600 shares/units after transaction. Holdings increased 84.62%.
Filing date: May 24, 2013. Record updated at 22:11:21.
 
TEJON RANCH CO (TRC)
First-Class Insider (President / CEO): STINE ROBERT A

Sold 13,100 Tejon Ranch Co. Common Stock (Non-Derivative security at $30.028) on May 24, 2013. Direct holding 33,025 shares/units after transaction. Holdings decreased -28.40%.
Filing date: May 24, 2013. Record updated at 22:11:08.
 
Cyclacel Pharmaceuticals, Inc. (CYCC)
First-Class Insider (President & C.E.O.): Rombotis Spiro George

Acquired 100,000 Common Stock, $0.001 par value per share (Non-Derivative security at $3.000) on May 21, 2013. Direct holding 241,416 shares/units after transaction. Holdings increased 70.71%.
Filing date: May 24, 2013. Record updated at 22:09:07.
 
Cornerstone OnDemand Inc (CSOD)
Director: BURLINGAME HAROLD W

Acquired 11,870 Common Stock (Non-Derivative security at $1.260) on May 22, 2013. Direct holding 45,120 shares/units after transaction. Holdings increased 35.70%.
Filing date: May 24, 2013. Record updated at 22:08:26.
 
MCKESSON CORP (MCK)
Senior Officer (EVP,GC & Chief Compl. Officer): Seeger Laureen

Sold 17,250 Common Stock (Non-Derivative security at $116.500) on May 24, 2013. Direct holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: May 24, 2013. Record updated at 22:07:18.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.